Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.
Journal Information
Full Title: J Gastroenterol
Abbreviation: J Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest The authors declare that they have no conflict of interest."
"Funding This study was funded by the Japanese Agency for Medical Research and Development (AMED), Practical Research Project for Rare/Intractable Diseases, JP17ek0109089."
"This phase-2a, randomized, double-blind, multi-center, placebo-controlled study was conducted at 17 medical centers in Japan. After approval by the Pharmacological and Medical Device Agency (PMDA), ethical approval for this study was obtained from the Institutional Review Board of the University of Miyazaki and those of the other centers. This clinical trial was conducted in compliance with ethical principles based on the Declaration of Helsinki, good clinical practice (GCP) of the Japanese Ministerial Ordinance, and other related regulation requirements. The trial is registered in the JAPIC clinical trials information; Japic CTI- 205255 (200410115290)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025